Moderately hypofractionated post-operative radiation therapy for breast cancer: Preferences amongst radiation oncologists from countries in Latin America and the Caribbean
Gustavo Nader Marta, Fabio Y. Moraes, Rejane Carolina de Oliveira Franco, Heloisa A. Carvalho, Andre Guimaraes Gouveia, Gustavo Cartaxo de Lima Gössling, Rafaela Gomes de Jesus, Gustavo Ferraris, Pablo Munoz Schuffenegger, Gustavo Sarria, Adela Poitevin Chacon, Raúl Murillo, Luis Ernesto Moreno Sánchez, Elizabeth Gamarra-Cabezas, Arthur Accioly Rosa, Mauricio Silva, Marcos Duarte de Mattos, Diego Chaves Rezende Morais, Douglas Guedes de Castro, Alan Dal Pra, Beatriz E Amendola, José Máximo Barros, Tomas Merino Lara, Nicolas Isa, Dolores de la Mata, Iván Hidalgo, Diego Giménez-Velilla, Lijia Aviles, Francisco Gomez Montenegro, Nestor O. Sanchez Chacin, Gustavo Werutsky, Gustavo Viani DOI: 10.5603/RPOR.a2023.0046 Full link: https://journals.viamedica.pl/rpor/article/view/96331
Radiotherapy combined or not with chemotherapy in adult or pedriatic patients with brainstem glioma: a population-bases study
Fabio Y. Moraes, Andre G. Gouveia , Gustavo N. Marta, Gustavo A. Viani DOI: 10.5603/RPOR.a2023.0016 Full link: https://journals.viamedica.pl/rpor/article/view/RPOR.a2023.0016
Assessing the efficacy of palliative radiation treatment schemes for locally advanced squamous cell carcinoma of the head and neck: a meta-analysis
Gustavo A. Viani, Andre G. Gouveia, Fernando K. Matsuura, Leonardo V.F. Neves, Gustavo N. Marta, Melvin L.K. Chua, and Y. Fabio Moraes DOI: 10.5603/RPOR.a2023.0021 Full link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348333/
A Meta-analysis of the Efficacy and Safety of Stereotactic Arrhythmia Radioablation (STAR) in Patients with Refractory Ventricular Tachycardia
G A Viani, A G Gouveia, J F Pavoni, A V Louie, J Detsky, D E Spratt, F Y Moraes DOI: 10.1016/j.clon.2023.04.004 Full link: https://pubmed.ncbi.nlm.nih.gov/37365062/
10 th. InterAmerican Oncology Conference ‘Current Status and Future of Anti-Cancer Targeted Therapies
The conference agenda will focus on new advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. Date: 6-7 JULY , 2023 HYBRID CONFERENCE: in person in Buenos Aires and virtual online. VENUE : Buenos Aires, Argentina. Conference secretariat : secretariat@oncologyconferences.com.ar Website: www.oncologyconferences.org See the full program
Abstract OT3-07-01: Real-World Data on First-line Treatment of HR-positive, HER2-negative, Metastatic Breast Cancer in Brazil (BRAVE Study/LACOG 0221)
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Abstract OT2-22-02: Sequencing of anthracyclines and taxanes during neoadjuvant therapy of locally advanced HER2-negative breast cancer (NEOSAMBA Study/LACOG 0419)
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Tumor, Patient, and Social Determinants of Health Affecting Survival in Patients With Anal Cancer Treated By Chemoradiation
Gustavo A. Viani, PhD, MD, Andre G. Gouveia, MD, MBA, Ianara N.S.B. Silva, MD ,Gustavo S. Fernandes, MD, Fabio Y. Moraes, PhD, MD DOI: 10.1016/j.ijrobp.2023.02.029. Epub 2023 Feb 23. Full link: https://pubmed.ncbi.nlm.nih.gov/36828170/
XXV Simposio de Revisiones en Cáncer
Fechas: 8, 9 y 10 de febrero 2023 Modalidad: presencial Enlace inscripción: https://www.revisionesencancer.com/#inscripciones Dirigido a: médicos, oncólogos y radioterapeutasEnlace a la web oficial del Congreso: https://www.revisionesencancer.com/ Programa de Revisiones en Cáncer 2023